RBC Research: Target => $63.Our view: Q1/18 results were largely in line with our forecasts. We continue to believe EQB is doing a good job executing on its growth strategy. However, our neutral outlook for the stock reflects our cautious (but not negative) outlook for the Canadian mortgage market and what we believe is reduced investor sentiment towards mortgage companies, which we think is likely to constrain sector valuation multiples until we see early signs of a positive catalyst emerging. For small-cap investors with a longer-term investment horizon compared to our 12-month outlook, we think the current share price is attractive.